Jonathan Hunt
Oren Beske
Dr. Oren Beske joined ATUM in 2019 and brings nearly 20 years of industry experience to the team. Notably, Dr. Beske was President of Aragen Biosciences, Inc. where he led a multidisciplinary team to bring value added services to the biologics industry. Most recently, he served as the CEO of Alloy Therapeutics, Inc. a start up antibody discovery platform company. Dr. Beske received a BS in Physiology and Biochemistry from CSULB and his Ph.D. in Cell Biology from UC San Francisco.
Tristan Höver
Tristan is the Senior Research Analyst of the Düsseldorf team at Euromonitor International. He is specialized on Pet Care and food & nutrition industries in the DACH region.In his current role, Tristan is responsible for analysing the latest trends and developments influencing the pet care, food and nutrition industries, with a focus on the German market, in a range of reports. Tristan also contributes directly to the quality of Euromonitor’s global research. His analysis has appeared in business publications like Handelsblatt and he has been a speaker at several renowned webinars and trade fairs such as Interzoo Academy, ISM Cologne and AnugaFoodTecTristan has completed an apprenticeship as an associate engineer as well as a degree in business psychology.
Take a look at Euromonitor's latest report on the Top 10 Global Consumer Trends of 2023 here: https://bit.ly/3XfAEzO
Access Tristan's presentation from Petcare Innovation Europe here: https://bit.ly/41hmEao
Matea Ugulin
Gregory Bombard
Gregory S. Bombard is a trial lawyer whose practice focuses on trade secret litigation. Greg also handles other IP litigation and complex commercial disputes. His trade secret clients are primarily in high tech industries, including biotech, medical devices, software, robotics, fintech, and manufacturing. Greg is an author of the ABA’s Guide to Protecting and Litigating Trade Secrets, 2nd Ed., and co-chairs of the ABA’s Trade Secret Litigation Subcommittee. Greg is a shareholder in the Boston office of the international law firm Greenberg Traurig, LLP. He can be reached at [email protected].
Kelly Knaapen Arts
Kelly is Senior Director, European Patents and IP Operations at Merus. She has a Master’s degree in Biomedical Sciences and started her career as European patent attorney in private practice. In 2019 she joined Merus, where she is responsible for the operation of the IP department, directs the IP strategy, and advances Merus’ patent portfolio relating to multispecific antibodies. Working together with several outside counsel and collaboration partners, her focus is on establishing a strong IP position and freedom to operate for Merus’ key platform technology and clinical and pre-clinical products to support Merus’ mission to close in on cancer.